Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

158

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

June 30, 2003

Conditions
Pancreatic Cancer
Interventions
DRUG

fluorouracil

5-fluorouracil will be administered via central venous catheter or PICC beginning at 250mg/m2/ day as continous infusion for a 28 day period.

DRUG

Irofulven

Irofulven will be given at 0.55 mg/kg per infusion on Day 1 and and Day 15 every 28 days as a 30 minute iv infusion.

Trial Locations (1)

55437

MGI Pharma, Incorporated, Bloomington

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY

NCT00033735 - Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer | Biotech Hunter | Biotech Hunter